← Back to all clusters

Cluster 365

5 diseases · 7 shared-gene connections
5 Diseases
7 Unique genes
0.273 Avg. similarity score
Dihydropyrimidine metabolism disorder Most-connected disease (4 links)
Log in to save this analysis

Save This Analysis

Disease Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Disease ⇵ Connections in cluster ⇵ Significant partners ⇵ Curated genes ⇵
Dihydropyrimidine metabolism disorder 4 4 2
1p21.3 microdeletion syndrome 3 3 1
Anal polyp 3 3 6
Dihydropyrimidine dehydrogenase deficiency 3 3 1
Dihydropyrimidinase deficiency 1 1 1

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
DPYD 4 / 5 1p21.3 microdeletion syndrome, Anal polyp, Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine metabolism disorder
DPYS 2 / 5 Dihydropyrimidinase deficiency, Dihydropyrimidine metabolism disorder
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Pyrimidine catabolism Reactome 2 / 11 312× 1.60e-5 4.96e-4 ✓ sig.
Pantothenate and CoA biosynthesis KEGG 2 / 21 163× 6.08e-5 1.50e-3 ✓ sig.
beta-Alanine metabolism KEGG 2 / 31 111× 1.34e-4 2.85e-3 ✓ sig.
Pyrimidine metabolism KEGG 2 / 58 59.2× 4.74e-4 7.65e-3 ✓ sig.
Drug metabolism - other enzymes KEGG 2 / 81 42.4× 9.23e-4 1.28e-2 ✓ sig.
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) Reactome 1 / 12 143× 6.97e-3 5.45e-2
Arachidonic acid metabolism KEGG 1 / 63 27.2× 3.62e-2 1.44e-1
Metabolic pathways KEGG 3 / 1,563 3.3× 5.13e-2 1.74e-1

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
uracil catabolic process GO:0006212 2 / 2 2,670× 1.20e-7 1.41e-5 ✓ sig.
thymine catabolic process GO:0006210 2 / 3 1,780× 3.61e-7 3.55e-5 ✓ sig.
CMP catabolic process GO:0006248 2 / 5 1,068× 1.20e-6 9.61e-5 ✓ sig.
dCMP catabolic process GO:0006249 2 / 6 890× 1.80e-6 1.33e-4 ✓ sig.
UMP catabolic process GO:0046050 2 / 6 890× 1.80e-6 1.33e-4 ✓ sig.
dUMP catabolic process GO:0046079 2 / 6 890× 1.80e-6 1.33e-4 ✓ sig.
pyrimidine nucleobase catabolic process GO:0006208 2 / 7 763× 2.52e-6 1.73e-4 ✓ sig.
purine nucleobase catabolic process GO:0006145 1 / 1 2,670× 3.75e-4 7.81e-3 ✓ sig.
thymidine catabolic process GO:0006214 1 / 1 2,670× 3.75e-4 7.81e-3 ✓ sig.
beta-alanine biosynthetic process GO:0019483 1 / 2 1,335× 7.49e-4 1.25e-2 ✓ sig.
regulation of fever generation GO:0031620 1 / 2 1,335× 7.49e-4 1.25e-2 ✓ sig.
negative regulation of RNA splicing GO:0033119 1 / 6 445× 2.25e-3 2.41e-2 ✓ sig.
positive regulation of protein tyrosine kinase activity GO:0061098 1 / 9 297× 3.37e-3 3.01e-2 ✓ sig.
positive regulation of prostaglandin secretion GO:0032308 1 / 9 297× 3.37e-3 3.01e-2 ✓ sig.
regulation of neural precursor cell proliferation GO:2000177 1 / 11 243× 4.11e-3 3.32e-2 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
1p21.3 microdeletion syndrome Dihydropyrimidine dehydrogenase deficiency 0.500 1 6.49e-5 2.34e-4 ✓ sig.
1p21.3 microdeletion syndrome Dihydropyrimidine metabolism disorder 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Dihydropyrimidinase deficiency Dihydropyrimidine metabolism disorder 0.333 1 1.30e-4 3.90e-4 ✓ sig.
Dihydropyrimidine dehydrogenase deficiency Dihydropyrimidine metabolism disorder 0.333 1 1.30e-4 3.90e-4 ✓ sig.
1p21.3 microdeletion syndrome Anal polyp 0.143 1 3.90e-4 8.52e-4 ✓ sig.
Anal polyp Dihydropyrimidine dehydrogenase deficiency 0.143 1 3.90e-4 8.52e-4 ✓ sig.
Anal polyp Dihydropyrimidine metabolism disorder 0.125 1 7.79e-4 1.39e-3 ✓ sig.